Placement of Trials Increasingly Dispersed
The distribution of locations for all trials registered on ClinicalTrials.gov.
The percentage of registered clinical trials being conducted at investigative sites outside of the U.S. continues to rise. According to data provided by http://ClinicalTrials.gov/ on the distribution of locations for all trials registered on the website, 45% reside in non-U.S. geographies.
The U.S., of course, continues to be the most active location for clinical research by size, with the country still home to 40% of all registered studies in the world. Six percent, or 10,572, of those trials in the http://ClinicalTrials.gov/ database have sites located in the U.S. as well as other global regions.
As of Sept. 23, a href="http://www.ClinicalTrials.gov" target="_blank" rel="nofollow">http://ClinicalTrials.gov/ included entries on 175,249 studies, with locations in 187 countries.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Ethical, Biosafety, and Scientific Review Considerations in Hematology and Oncology Clinical Trials
September 10th 2024The current oncology and hematology drug development pipeline features a wide array of large molecule therapeutics. As a result, clinical trial protocols have grown more complex, requiring sponsors, CROs, and research sites to tackle a variety of challenges that were less common with older, more traditional therapies.
